Content about Thousand Oaks, California

October 22, 2013

Biotech drug maker Amgen has acquired from Roche the rights to drugs used to boost the immune systems of cancer patients on chemotherapy in 100 markets.

THOUSAND OAKS, Calif. — Biotech drug maker Amgen has acquired from Roche the rights to drugs used to boost the immune systems of cancer patients on chemotherapy in 100 markets.

October 31, 2012

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

HOLZKIRCHEN, Germany — Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

Sandoz, the generics arm of Swiss drug maker Novartis, said it had started enrolling patients for a phase-3 study of epoetin alfa, a biosimilar version of Epogen and Procrit, made by Amgen and Johnson & Johnson and used to treat anemia associated with chronic kidney disease.

November 4, 2010

Biotech company Amgen took home a top award for one of its drugs at an...

THOUSAND OAKS, Calif. Biotech company Amgen took home a top award for one of its drugs at an annual event for drug makers, the company said Friday.

 

Amgen won the Best New Drug award for the osteoporosis treatment Prolia (denosumab) at the 2010 Scrip Awards in London Thursday.

 

The drug works by targeting the cells that break down bone, called osteoclasts, and was named one of the top 10 medical breakthroughs of 2009 in Time magazine.